1. Movano announces new features for the Evie Ring app supporting women's wellness. 2. Features include data personalization, trend tracking, and Apple Health integration. 3. Evie Ring priced at $269, eligible for HSA/FSA reimbursement. 4. Tyla Bucher states enhancements are based on community feedback. 5. Future upgrades are planned to improve the Evie user experience.
The introduction of new features enhances user engagement, potentially increasing sales. Historical trends show that product innovation usually boosts stock prices in tech wearables.
The article discusses significant product enhancements that may drive interest and sales, and provides timely insights into Movano's market positioning.
Immediate improvements can attract consumers quickly, impacting short-term sales positively. Previous examples include immediate stock gains following product updates in technology firms.
PLEASANTON, Calif., March 10, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology and maker of the Evie Ring, today announced a series of new data personalization, trend tracking and integration features on the ring's companion app that expand support for women's wellness journeys. The enhancements follow January's beta release of EvieAI, the first wearable-based virtual wellness assistant built exclusively with training data from medical journals.
Available immediately on the iOS version of the Evie app, the new features include:
"Every new feature we add is designed to help women navigate their wellness journey, whether through more personalization, easier trend analysis, or correlations across multiple metrics to provide insights that can help users optimize their daily routines," said Movano Chief Marketing Officer Tyla Bucher. "These latest upgrades represent the most requested enhancements from the Evie community, and we have many others in the pipeline that will continue to enrich the Evie experience."
The Evie Ring costs $269 with no subscription fees, keeping costs low over the life of the wearable, and is eligible for HSA/FSA fund reimbursement. It is compatible with both Apple and Android devices, and is available exclusively at www.eviering.com in gold, rose gold and silver finishes and in sizes 5-12 with an optional complimentary sizing kit for those who don't know their ring size.
Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health is developing a suite of purpose-driven healthcare solutions to bring medical-grade data to the forefront of wearables. Featuring modern and flexible form factors, Movano Health's Evie and EvieMED devices offer an innovative approach to delivering trusted data to both customers and enterprises, capturing a comprehensive picture of an individual's health data and uniquely translating it into personalized and intelligent insights. Movano Health's proprietary technologies and wearable medical device solutions enable the use of data as a tool to proactively monitor and manage health outcomes. For more information visit https://movanohealth.com/.
This press release contains forward-looking statements concerning our expectations, anticipations, intentions, beliefs, or strategies regarding the future. These forward-looking statements are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially from those anticipated. Therefore, you should not place undue reliance on forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding plans with respect to the commercial launches of the Evie Ring and EvieMED; our expectations regarding potential commercial opportunities and addressable markets; planned cost-cutting initiatives; anticipated FDA clearance decisions with respect to our products; expected future operating results; product development efforts and product releases; clinical trial and regulatory initiatives; commercial partner activities; our strategies, positioning and expectations for future events or performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission, including under the caption "Risk Factors." Any forward-looking statement in this release speaks only as of the date of this release. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
SOURCE Movano